Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $31,530 | 1,119 | 99.4% |
| Education | $193.98 | 17 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,285 | 89 | $0 (2024) |
| Amgen Inc. | $2,970 | 85 | $0 (2024) |
| Novo Nordisk Inc | $2,573 | 133 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,875 | 48 | $0 (2024) |
| Lilly USA, LLC | $1,548 | 83 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,290 | 52 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,255 | 39 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $985.22 | 35 | $0 (2024) |
| Allergan, Inc. | $959.92 | 21 | $0 (2020) |
| Eisai Inc. | $847.82 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,486 | 86 | AstraZeneca Pharmaceuticals LP ($810.80) |
| 2023 | $2,654 | 82 | Abbott Laboratories ($364.04) |
| 2022 | $3,427 | 129 | Medtronic, Inc. ($308.62) |
| 2021 | $3,772 | 136 | AstraZeneca Pharmaceuticals LP ($597.30) |
| 2020 | $2,344 | 105 | AstraZeneca Pharmaceuticals LP ($430.98) |
| 2019 | $4,738 | 147 | Amgen Inc. ($791.29) |
| 2018 | $5,363 | 206 | Amgen Inc. ($619.98) |
| 2017 | $5,941 | 245 | Janssen Pharmaceuticals, Inc ($587.98) |
All Payment Transactions
1,136 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Neurology | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $117.19 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Endocrinology | ||||||
| 10/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $120.00 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| Category: GI | ||||||
| 10/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $63.33 | General |
| Category: Obesity | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Neurology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardio-renal | ||||||
| 08/26/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/22/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Endocrinology | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 2,176 | 19,738 | $664,222 | $224,469 |
| 2022 | 54 | 3,510 | 20,877 | $1.1M | $399,458 |
| 2021 | 58 | 3,862 | 18,505 | $957,473 | $442,051 |
| 2020 | 49 | 3,054 | 19,469 | $665,709 | $306,503 |
All Medicare Procedures & Services
208 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 389 | 1,085 | $271,820 | $92,985 | 34.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 77 | 78 | $42,276 | $15,756 | 37.3% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 75 | 149 | $37,250 | $14,217 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $22,360 | $10,692 | 47.8% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 76 | 76 | $18,164 | $7,113 | 39.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 75 | 75 | $22,500 | $6,588 | 29.3% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 76 | 76 | $16,492 | $6,258 | 37.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 41 | 41 | $20,500 | $5,252 | 25.6% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 49 | 49 | $12,760 | $4,940 | 38.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 69 | 75 | $12,375 | $4,792 | 38.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 37 | 37 | $18,500 | $4,688 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 70 | $12,216 | $4,505 | 36.9% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 75 | 75 | $13,050 | $4,207 | 32.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 130 | 349 | $10,470 | $3,451 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 27 | $9,504 | $3,194 | 33.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 40 | 98 | $9,800 | $3,139 | 32.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 18 | 20 | $10,000 | $2,792 | 27.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $6,480 | $2,598 | 40.1% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 29 | 29 | $6,670 | $2,455 | 36.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 25 | 76 | $8,360 | $2,418 | 28.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 13 | 13 | $6,123 | $2,344 | 38.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 72 | 94 | $2,820 | $2,321 | 82.3% |
| 97760 | Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | Office | 2023 | 43 | 62 | $4,960 | $1,957 | 39.4% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 17 | 19 | $9,500 | $1,717 | 18.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 20 | 20 | $5,000 | $1,664 | 33.3% |
About Dr. Sumedha Dalvi, M.D
Dr. Sumedha Dalvi, M.D is a Internal Medicine healthcare provider based in Fayetteville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255400321.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sumedha Dalvi, M.D has received a total of $31,724 in payments from pharmaceutical and medical device companies, with $3,486 received in 2024. These payments were reported across 1,136 transactions from 77 companies. The most common payment nature is "Food and Beverage" ($31,530).
As a Medicare-enrolled provider, Dalvi has provided services to 12,602 Medicare beneficiaries, totaling 78,589 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 208 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Fayetteville, NC
- Active Since 11/06/2006
- Last Updated 10/14/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255400321
Products in Payments
- FARXIGA (Drug) $1,827
- JARDIANCE (Drug) $1,184
- Aimovig (Biological) $1,184
- CAPLYTA (Drug) $1,103
- Ozempic (Drug) $1,077
- XARELTO (Drug) $1,060
- ENTRESTO (Drug) $992.56
- VRAYLAR (Drug) $890.21
- Repatha (Biological) $852.91
- INVOKANA (Drug) $809.38
- Vascepa (Drug) $741.39
- Otezla (Drug) $645.57
- XIFAXAN (Drug) $596.98
- INTELLIS ADAPTIVESTIM (Device) $485.27
- Kerendia (Drug) $479.12
- Fycompa (Drug) $466.94
- Tresiba (Drug) $441.29
- EMGALITY (Drug) $386.64
- BREZTRI (Drug) $372.20
- TRULICITY (Drug) $362.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fayetteville
Dr. Eugene Wright, M.d, M.D
Internal Medicine — Payments: $968,535
Catherine Kilpatrick, M.d, M.D
Internal Medicine — Payments: $777,138
Dr. Nicole Greyshock, Md, MD
Internal Medicine — Payments: $387,661
Dr. Frederick Asare, Md, MD
Internal Medicine — Payments: $59,642
Sandip Patel, Md, MD
Internal Medicine — Payments: $42,449
Dr. Hari Saini, M.d, M.D
Internal Medicine — Payments: $33,331